-
Eric Minikel, Sonia Vallabh: A genetically informed paradigm for primary prevention of prion disease
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
published: 03 Mar 2022
-
Lifting The Veil Lecture Series Part-1A
TamBo Foundation, Clinical Trials Participation, A Compelling Case in African and Afro-Diasporic communities, Lecture Series, Cancer, Virtual conversations, awareness
published: 01 Apr 2021
-
Enhancing Neurodevelopmental Resilience from Conception to Adulthood
(04:34 - Main Presentation, 57:59 - Audience Questions) Robert L Hendren, DO, Professor of Psychiatry and Behavioral Science discusses how to build resilience in children with or at risk of neurodevelopmental disorders through innovative biomedical and resilience enhancing interventions. Recorded on 03/04/2021. [Show ID: 36870]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programm...
published: 03 Apr 2021
-
From the “Baldwin Effect” to Genes of Small Effect: Celebrating the Work of David Depew - Session 2
The NHGRI History of Genomics Program hosts "From the 'Baldwin Effect' to Genes of Small Effect: Celebrating the Work of David Depew." Dr. Depew, Professor Emeritus at University of Iowa, was among the first to address the fundamental legacies of Aristotle in modern biology. The one-day conference focuses on themes in Depew’s work across the history and philosophy of biology.
More: https://www.genome.gov/event-calendar/From-the-Baldwin-Effect-to-Genes-of-Small-Effect-Celebrating-the-Work-of-David-Depew
Chapters:
0:00 - Introduction (Chris Donohue)
0:13 - Vitalism and the emergence of biology (Charles Wolfe)
30:41 - Q&A; with Charles Wolfe
48:21 - Always Historicize: The Evolutionary Synthesis and the Extended Synthesis, in Context
(Betty Smocovitis)
1:20:09 - Q&A; with Betty Smocovitis
published: 16 Aug 2021
-
Beyond the Human Genome: A Million Person Precision Population Health Project
Prof. Dr. Leroy Hood
CEO/Founder, Phenome Health, Seattle | USA
The vision of this project is that we will develop the infrastructure to employ a data-driven (genome/phenome analyses) approach to optimizing the health trajectory of individuals for body and brain. We have two large populations (5000 and 10,000) that have respectively validated this approach for body and brain health, respectively. These studies have led to us pioneering the science of wellness and prevention as I will discussed in the lecture. This project has required the acquisition of key partners for execution which will be necessary. We are approaching the Federal Government for funding for this project, as we did for the first Human Genome Project. This project is one of perhaps 10 or so 500,000 to one million p...
published: 13 Nov 2022
-
This House Believes Genetic Modification of Humans is the Future of Healthcare | Cambridge Union
WANT TO KNOW MORE:
SUBSCRIBE for more speakers: https://www.youtube.com/channel/UClOu...
Find out when our next event is on FACEBOOK: https://www.facebook.com/TheCambridge...
ABOUT THE MOTION: This House Believes Genetic Modification of Humans is the Future of Healthcare
In 2018, the world saw the first gene-edited babies using CRISPR--‐Cas9. With this act, the genetic modification of human beings became plausible – even attainable. Therefore, in our Week 4 debate, the Cambridge Union has paired up with Astra Zeneca to ask how far the genetic modification of human beings will be possible in the future and, crucially, whether we should embrace it for medical purposes. (This debate is sponsored by Astra Zeneca.)
ABOUT THE SPEAKERS:
PROPOSITION
1) Fiona Watt: Executive Chair of the Medic...
published: 29 Apr 2019
-
REW Keynote: Gene Therapy and Gene Editing for Orphan Diseases
In this Research and Education Week keynote lecture, James M. Wilson, M.D., Ph.D., discusses differentiating between gene therapy from genome editing and barriers to success in these fields.
published: 30 Apr 2019
-
Rachid Karam, Ambry Genetics- Utiliz of NGS Multi Gene Panel Testing in Hereditary Cancer Dx
Rachid Karam, M.D., Ph.D., Variant Assessment Specialist, Ambry Genetics
Over the past few years, the clinical availability and utilization of multi-gene hereditary cancer panels has transformed hereditary cancer diagnostics. Here, we summarize our results and experience from a large cohort of patients referred for multi-gene hereditary cancer panel testing at our CAP-accredited, CLIA-licensed Molecular Diagnostic Laboratory (Ambry Genetics, Aliso Viejo, CA). Content is focused on expanding phenotypes of known cancer predisposition syndromes and the impact of panel results on cancer treatment and risk management.
For more information go to PMWCintl.com
published: 11 May 2015
-
A genetically informed paradigm for primary prevention of prion disease (Simplified Chinese)
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
published: 16 May 2022
-
Considerations for Rare Plants
CNPS Genetics Symposium 2020
Protecting California’s Diversity: Genetic Considerations for Native Planting and Restoration
Session A: Considerations for Rare Plants
Speaker: Michele Dudash
Consideration of a paradigm shift in the genetic management of fragmented populations
Speaker: Amy Vandergast
Regional genetic distinctiveness among remaining populations of an endangered salt marsh plant in California and conservation strategies
Speaker: Andrea Kramer
Considerations when mixing source populations to restore rare plants
Speaker: Loraine Washburn
The ghosts of translocations past, present, and yet to come: Applying inexact molecular tools to rare plants on shifting landscapes
Questions/discussion with the panel
Abstracts available: bit.ly/program1016
published: 09 Nov 2020
1:00:19
Eric Minikel, Sonia Vallabh: A genetically informed paradigm for primary prevention of prion disease
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from pr...
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
https://wn.com/Eric_Minikel,_Sonia_Vallabh_A_Genetically_Informed_Paradigm_For_Primary_Prevention_Of_Prion_Disease
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
- published: 03 Mar 2022
- views: 883
49:43
Lifting The Veil Lecture Series Part-1A
TamBo Foundation, Clinical Trials Participation, A Compelling Case in African and Afro-Diasporic communities, Lecture Series, Cancer, Virtual conversations, awa...
TamBo Foundation, Clinical Trials Participation, A Compelling Case in African and Afro-Diasporic communities, Lecture Series, Cancer, Virtual conversations, awareness
https://wn.com/Lifting_The_Veil_Lecture_Series_Part_1A
TamBo Foundation, Clinical Trials Participation, A Compelling Case in African and Afro-Diasporic communities, Lecture Series, Cancer, Virtual conversations, awareness
- published: 01 Apr 2021
- views: 63
1:14:40
Enhancing Neurodevelopmental Resilience from Conception to Adulthood
(04:34 - Main Presentation, 57:59 - Audience Questions) Robert L Hendren, DO, Professor of Psychiatry and Behavioral Science discusses how to build resilience i...
(04:34 - Main Presentation, 57:59 - Audience Questions) Robert L Hendren, DO, Professor of Psychiatry and Behavioral Science discusses how to build resilience in children with or at risk of neurodevelopmental disorders through innovative biomedical and resilience enhancing interventions. Recorded on 03/04/2021. [Show ID: 36870]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)
https://wn.com/Enhancing_Neurodevelopmental_Resilience_From_Conception_To_Adulthood
(04:34 - Main Presentation, 57:59 - Audience Questions) Robert L Hendren, DO, Professor of Psychiatry and Behavioral Science discusses how to build resilience in children with or at risk of neurodevelopmental disorders through innovative biomedical and resilience enhancing interventions. Recorded on 03/04/2021. [Show ID: 36870]
Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.
Explore More Health & Medicine on UCTV
(https://www.uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.
UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)
- published: 03 Apr 2021
- views: 2623
1:34:30
From the “Baldwin Effect” to Genes of Small Effect: Celebrating the Work of David Depew - Session 2
The NHGRI History of Genomics Program hosts "From the 'Baldwin Effect' to Genes of Small Effect: Celebrating the Work of David Depew." Dr. Depew, Professor Emer...
The NHGRI History of Genomics Program hosts "From the 'Baldwin Effect' to Genes of Small Effect: Celebrating the Work of David Depew." Dr. Depew, Professor Emeritus at University of Iowa, was among the first to address the fundamental legacies of
Aristotle in modern biology. The one-day conference focuses on themes in Depew’s work across the history and philosophy of biology.
More: https://www.genome.gov/event-calendar/From-the-Baldwin-Effect-to-Genes-of-Small-Effect-Celebrating-the-Work-of-David-Depew
Chapters:
0:00 - Introduction (Chris Donohue)
0:13 - Vitalism and the emergence of biology (Charles Wolfe)
30:41 - Q&A; with Charles Wolfe
48:21 - Always Historicize: The Evolutionary Synthesis and the Extended Synthesis, in Context
(Betty Smocovitis)
1:20:09 - Q&A; with Betty Smocovitis
https://wn.com/From_The_“Baldwin_Effect”_To_Genes_Of_Small_Effect_Celebrating_The_Work_Of_David_Depew_Session_2
The NHGRI History of Genomics Program hosts "From the 'Baldwin Effect' to Genes of Small Effect: Celebrating the Work of David Depew." Dr. Depew, Professor Emeritus at University of Iowa, was among the first to address the fundamental legacies of
Aristotle in modern biology. The one-day conference focuses on themes in Depew’s work across the history and philosophy of biology.
More: https://www.genome.gov/event-calendar/From-the-Baldwin-Effect-to-Genes-of-Small-Effect-Celebrating-the-Work-of-David-Depew
Chapters:
0:00 - Introduction (Chris Donohue)
0:13 - Vitalism and the emergence of biology (Charles Wolfe)
30:41 - Q&A; with Charles Wolfe
48:21 - Always Historicize: The Evolutionary Synthesis and the Extended Synthesis, in Context
(Betty Smocovitis)
1:20:09 - Q&A; with Betty Smocovitis
- published: 16 Aug 2021
- views: 414
36:32
Beyond the Human Genome: A Million Person Precision Population Health Project
Prof. Dr. Leroy Hood
CEO/Founder, Phenome Health, Seattle | USA
The vision of this project is that we will develop the infrastructure to employ a data-driven (...
Prof. Dr. Leroy Hood
CEO/Founder, Phenome Health, Seattle | USA
The vision of this project is that we will develop the infrastructure to employ a data-driven (genome/phenome analyses) approach to optimizing the health trajectory of individuals for body and brain. We have two large populations (5000 and 10,000) that have respectively validated this approach for body and brain health, respectively. These studies have led to us pioneering the science of wellness and prevention as I will discussed in the lecture. This project has required the acquisition of key partners for execution which will be necessary. We are approaching the Federal Government for funding for this project, as we did for the first Human Genome Project. This project is one of perhaps 10 or so 500,000 to one million person projects world-wide and it is unique in that it will carry out longitudinal phenome analyses, it will return results to participants and it is creating the infrastructure to spread this approach across the US and world healthcare systems. This project will lead to a powerful data ecosystem that will generate new knowledge about medicine, will catalyze the initiation of many start-up companies and will catalyze a paradigm shift in healthcare from its current disease orientation to a wellness and prevention orientation. This effort will catalyze the largest paradigm shift in medicine ever.
https://phenomehealth.org/
https://wn.com/Beyond_The_Human_Genome_A_Million_Person_Precision_Population_Health_Project
Prof. Dr. Leroy Hood
CEO/Founder, Phenome Health, Seattle | USA
The vision of this project is that we will develop the infrastructure to employ a data-driven (genome/phenome analyses) approach to optimizing the health trajectory of individuals for body and brain. We have two large populations (5000 and 10,000) that have respectively validated this approach for body and brain health, respectively. These studies have led to us pioneering the science of wellness and prevention as I will discussed in the lecture. This project has required the acquisition of key partners for execution which will be necessary. We are approaching the Federal Government for funding for this project, as we did for the first Human Genome Project. This project is one of perhaps 10 or so 500,000 to one million person projects world-wide and it is unique in that it will carry out longitudinal phenome analyses, it will return results to participants and it is creating the infrastructure to spread this approach across the US and world healthcare systems. This project will lead to a powerful data ecosystem that will generate new knowledge about medicine, will catalyze the initiation of many start-up companies and will catalyze a paradigm shift in healthcare from its current disease orientation to a wellness and prevention orientation. This effort will catalyze the largest paradigm shift in medicine ever.
https://phenomehealth.org/
- published: 13 Nov 2022
- views: 100
1:18:15
This House Believes Genetic Modification of Humans is the Future of Healthcare | Cambridge Union
WANT TO KNOW MORE:
SUBSCRIBE for more speakers: https://www.youtube.com/channel/UClOu...
Find out when our next event is on FACEBOOK: https://www.facebook.com/...
WANT TO KNOW MORE:
SUBSCRIBE for more speakers: https://www.youtube.com/channel/UClOu...
Find out when our next event is on FACEBOOK: https://www.facebook.com/TheCambridge...
ABOUT THE MOTION: This House Believes Genetic Modification of Humans is the Future of Healthcare
In 2018, the world saw the first gene-edited babies using CRISPR--‐Cas9. With this act, the genetic modification of human beings became plausible – even attainable. Therefore, in our Week 4 debate, the Cambridge Union has paired up with Astra Zeneca to ask how far the genetic modification of human beings will be possible in the future and, crucially, whether we should embrace it for medical purposes. (This debate is sponsored by Astra Zeneca.)
ABOUT THE SPEAKERS:
PROPOSITION
1) Fiona Watt: Executive Chair of the Medical Research Council
2) Ultan McDermott: Chief Scientist, Oncology, AstraZeneca
3) Robin Lovell-Badge: Head of the Laboratory of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute
OPPOSITION
1) Anjana Ahuja: Science Commentator at the Financial Times and a regular contributor to BBC Newsnight and Prospect
2) Angela Xia: A second-year undergraduate studying Economics at Selwyn College of the University of Cambridge. Angela was chosen by open audition.
3: Frederick Nielsen: An MPhil reading Early Modern History at Peterhouse College of the University of Cambridge. Fred was chosen by open audition.
ABOUT THE CAMBRIDGE UNION: From its small beginnings as a debating society, the Cambridge Union is the oldest debating society in the world and the largest student society in Cambridge. The Union remains a unique forum for the free exchange of ideas and the art of public debate.
https://wn.com/This_House_Believes_Genetic_Modification_Of_Humans_Is_The_Future_Of_Healthcare_|_Cambridge_Union
WANT TO KNOW MORE:
SUBSCRIBE for more speakers: https://www.youtube.com/channel/UClOu...
Find out when our next event is on FACEBOOK: https://www.facebook.com/TheCambridge...
ABOUT THE MOTION: This House Believes Genetic Modification of Humans is the Future of Healthcare
In 2018, the world saw the first gene-edited babies using CRISPR--‐Cas9. With this act, the genetic modification of human beings became plausible – even attainable. Therefore, in our Week 4 debate, the Cambridge Union has paired up with Astra Zeneca to ask how far the genetic modification of human beings will be possible in the future and, crucially, whether we should embrace it for medical purposes. (This debate is sponsored by Astra Zeneca.)
ABOUT THE SPEAKERS:
PROPOSITION
1) Fiona Watt: Executive Chair of the Medical Research Council
2) Ultan McDermott: Chief Scientist, Oncology, AstraZeneca
3) Robin Lovell-Badge: Head of the Laboratory of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute
OPPOSITION
1) Anjana Ahuja: Science Commentator at the Financial Times and a regular contributor to BBC Newsnight and Prospect
2) Angela Xia: A second-year undergraduate studying Economics at Selwyn College of the University of Cambridge. Angela was chosen by open audition.
3: Frederick Nielsen: An MPhil reading Early Modern History at Peterhouse College of the University of Cambridge. Fred was chosen by open audition.
ABOUT THE CAMBRIDGE UNION: From its small beginnings as a debating society, the Cambridge Union is the oldest debating society in the world and the largest student society in Cambridge. The Union remains a unique forum for the free exchange of ideas and the art of public debate.
- published: 29 Apr 2019
- views: 2429
55:55
REW Keynote: Gene Therapy and Gene Editing for Orphan Diseases
In this Research and Education Week keynote lecture, James M. Wilson, M.D., Ph.D., discusses differentiating between gene therapy from genome editing and barrie...
In this Research and Education Week keynote lecture, James M. Wilson, M.D., Ph.D., discusses differentiating between gene therapy from genome editing and barriers to success in these fields.
https://wn.com/Rew_Keynote_Gene_Therapy_And_Gene_Editing_For_Orphan_Diseases
In this Research and Education Week keynote lecture, James M. Wilson, M.D., Ph.D., discusses differentiating between gene therapy from genome editing and barriers to success in these fields.
- published: 30 Apr 2019
- views: 1492
11:42
Rachid Karam, Ambry Genetics- Utiliz of NGS Multi Gene Panel Testing in Hereditary Cancer Dx
Rachid Karam, M.D., Ph.D., Variant Assessment Specialist, Ambry Genetics
Over the past few years, the clinical availability and utilization of multi-gene hered...
Rachid Karam, M.D., Ph.D., Variant Assessment Specialist, Ambry Genetics
Over the past few years, the clinical availability and utilization of multi-gene hereditary cancer panels has transformed hereditary cancer diagnostics. Here, we summarize our results and experience from a large cohort of patients referred for multi-gene hereditary cancer panel testing at our CAP-accredited, CLIA-licensed Molecular Diagnostic Laboratory (Ambry Genetics, Aliso Viejo, CA). Content is focused on expanding phenotypes of known cancer predisposition syndromes and the impact of panel results on cancer treatment and risk management.
For more information go to PMWCintl.com
https://wn.com/Rachid_Karam,_Ambry_Genetics_Utiliz_Of_Ngs_Multi_Gene_Panel_Testing_In_Hereditary_Cancer_Dx
Rachid Karam, M.D., Ph.D., Variant Assessment Specialist, Ambry Genetics
Over the past few years, the clinical availability and utilization of multi-gene hereditary cancer panels has transformed hereditary cancer diagnostics. Here, we summarize our results and experience from a large cohort of patients referred for multi-gene hereditary cancer panel testing at our CAP-accredited, CLIA-licensed Molecular Diagnostic Laboratory (Ambry Genetics, Aliso Viejo, CA). Content is focused on expanding phenotypes of known cancer predisposition syndromes and the impact of panel results on cancer treatment and risk management.
For more information go to PMWCintl.com
- published: 11 May 2015
- views: 281
1:00:18
A genetically informed paradigm for primary prevention of prion disease (Simplified Chinese)
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from pr...
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
https://wn.com/A_Genetically_Informed_Paradigm_For_Primary_Prevention_Of_Prion_Disease_(Simplified_Chinese)
There are few stories in science more inspiring than that of Dr Sonia Vallabh and Dr Eric Minikel. After seeing her mother rapidly decline and pass away from prion disease Sonia found out that she also carried the genetic variant that caused the disease. With an unknown timeline until Sonia will likely also succumb to the disease, Eric and Sonia both left their previous careers and retrained as scientists in pursuit of a cure. The Centre for Personalised Medicine is delighted to host Eric and Sonia to tell us more about their story, how they engage with a rare disease community, and their incredible progress towards developing a preventative treatment.
- published: 16 May 2022
- views: 116
1:18:56
Considerations for Rare Plants
CNPS Genetics Symposium 2020
Protecting California’s Diversity: Genetic Considerations for Native Planting and Restoration
Session A: Considerations for Rare P...
CNPS Genetics Symposium 2020
Protecting California’s Diversity: Genetic Considerations for Native Planting and Restoration
Session A: Considerations for Rare Plants
Speaker: Michele Dudash
Consideration of a paradigm shift in the genetic management of fragmented populations
Speaker: Amy Vandergast
Regional genetic distinctiveness among remaining populations of an endangered salt marsh plant in California and conservation strategies
Speaker: Andrea Kramer
Considerations when mixing source populations to restore rare plants
Speaker: Loraine Washburn
The ghosts of translocations past, present, and yet to come: Applying inexact molecular tools to rare plants on shifting landscapes
Questions/discussion with the panel
Abstracts available: bit.ly/program1016
https://wn.com/Considerations_For_Rare_Plants
CNPS Genetics Symposium 2020
Protecting California’s Diversity: Genetic Considerations for Native Planting and Restoration
Session A: Considerations for Rare Plants
Speaker: Michele Dudash
Consideration of a paradigm shift in the genetic management of fragmented populations
Speaker: Amy Vandergast
Regional genetic distinctiveness among remaining populations of an endangered salt marsh plant in California and conservation strategies
Speaker: Andrea Kramer
Considerations when mixing source populations to restore rare plants
Speaker: Loraine Washburn
The ghosts of translocations past, present, and yet to come: Applying inexact molecular tools to rare plants on shifting landscapes
Questions/discussion with the panel
Abstracts available: bit.ly/program1016
- published: 09 Nov 2020
- views: 197